Aguiar Leticia Lima, Martins Marina Guerra, Silva Renan Alves, Moreira Thereza Maria Magalhães, Almeida Paulo César de, Caetano Joselany Áfio
Universidade Federal do Ceará. Fortaleza, Ceará, Brazil.
Universidade Federal de Campina Grande. Cajazeiras, Paraíba, Brazil.
Rev Bras Enferm. 2025 Aug 8;78(3):e20240327. doi: 10.1590/0034-7167-2024-0327. eCollection 2025.
to analyze evidence of the validity and reliability of the Chronic Kidney Disease Patient Safety Assessment Scale in Hemodialysis Sessions (EASPRCH).
a methodological study with an analysis of validity evidence (content and construct) and reliability (temporal stability, internal consistency, and parameterization). A total of 11 judges and 240 patients from three hemodialysis clinics participated.
the EASPRCH consists of 15 items distributed across three domains: (1) Strategic Procedures for Error Prevention (6 items), (2) Organizational Processes in Health Management (5 items), and (3) Care Practices for Infection Control (4 items), with scoring available both by domain and overall. The scale has a maximum score of 45 points and a cutoff point (adequate/inadequate) of 34. It achieved a Cronbach's alpha of 0.78 and explained 72.41% of the total variance.
the scale provides evidence of weaknesses or strengths related to specific indicators, which may or may not impact patient safety in hemodialysis care.
分析血液透析治疗中慢性肾脏病患者安全评估量表（EASPRCH）的有效性和可靠性证据。
一项方法学研究，分析有效性证据（内容和结构）及可靠性（时间稳定性、内部一致性和参数化）。共有来自三家血液透析诊所的11名评判员和240名患者参与。
EASPRCH由15个项目组成，分布在三个领域：（1）预防错误的战略程序（6项），（2）健康管理中的组织流程（5项），以及（3）感染控制护理措施（4项），可按领域和总体进行评分。该量表最高分为45分，临界点（合格/不合格）为34分。其Cronbach's α系数为0.78，解释了总方差的72.41%。
该量表提供了与特定指标相关的优缺点证据，这些指标可能会也可能不会影响血液透析护理中的患者安全。
